German Primate Center
The scientists of the German Primate Center (Deutsches Primatenzentrum, DPZ) research basic biological and biomedical questions about the functioning of the body and about evolution and behavior by studying non-human primates. This includes studies of primate populations in the wild, performed on four field stations in natural primate habitats. The institute is structured by the three sections infection research, neuroscience and organismic primate biology. The DPZ, member of the Leibniz Association, also provides service for the German science community. This includes providing non-human primates as model organisms, endocrinologic and genetical analyses, reference data from databanks and pathological studies. The institute employs about 400 people.
Collaborate Research Center
Collaborative Research Unit
- Joint Lab: Auditory Neuroscience group
- FOR 2136: Sociality and health in primates
- CRC 889: Cellular Mechanisms of Sensory Processing
GAUG, MPI EM, MPI DS, MPI BC, DPZ, UMG, ENI
The DPZ is affiliated with the following centers on Campus:
Graduate Study Programs
The DPZ participates in the following graduate study programs:
- Leibniz Graduate School for the Emerging Infectious Deseases (EIDIS)
- International Max Planck Research School: Neurosciences
- International Max Planck Research School: Physics of Biological and Complex Systems
- International Max Planck Research School: Molecular Biosciences
- Research Training Group 2070 Understanding Social Relationships
Hot of the press: The latest issue of DPZ aktuell
In the latest issue (3/2016), the DPZ reports on why monkeys and people become more selective as they age, how our brain...
The German Primate Center´s 40th anniversary
In 2017 the DPZ will be celebrating its 40th anniversary with a variety of events.
Exhibition: DPZ presents insights into the brain
An exhibition at the German Primate Center presents fascinating images of the brain
The Ebola mobile suitcase laboratory successfully tested in Guinea
Scientists confirmed the efficiency of the novel Ebola detection method in field trials